Board Meeting25 Apr 2026, 08:30 pm
Nath Bio-Genes Board Meeting on May 4, 2026 to Approve Financial Results
AI Summary
Nath Bio-Genes (India) Ltd has scheduled a Board of Directors meeting on May 4, 2026, to consider and approve the audited financial results (standalone and consolidated) for the fourth quarter and year ended March 31, 2026. The board will also consider recommending a dividend for the year 2025-26, subject to shareholder approval. The company's trading window, which was closed on March 31, 2026, will reopen on May 6, 2026.
Key Highlights
- Board meeting scheduled for May 4, 2026 to approve financial results.
- Audited financial results for Q4 and FY26 will be considered.
- Dividend recommendation for FY26 to be discussed.
- Trading window to reopen on May 6, 2026.
Price Impact
More from NATHBIOGEN